These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 687104)

  • 21. Genetic counselling and prophylactic surgery in women from families with hereditary breast or ovarian cancer.
    Lobb E; Meiser B
    Lancet; 2004 Jun; 363(9424):1841-2. PubMed ID: 15183619
    [No Abstract]   [Full Text] [Related]  

  • 22. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
    Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
    JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.
    Antonucci I; Provenzano M; Sorino L; Balsamo M; Aceto GM; Battista P; Euhus D; Cianchetti E; Ballerini P; Natoli C; Palka G; Stuppia L
    J Hum Genet; 2017 Mar; 62(3):379-387. PubMed ID: 27928164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial breast and ovarian cancer: genetic counseling and clinical management in Italy.
    Pasini B; Pierotti MA
    Dis Markers; 1999 Oct; 15(1-3):41-3. PubMed ID: 10595250
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk-reduction surgery decisions in high-risk women seen for genetic counseling.
    Ray JA; Loescher LJ; Brewer M
    J Genet Couns; 2005 Dec; 14(6):473-84. PubMed ID: 16388328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: first experiences with patient perceptions, surveillance behavior and acceptance of genetic testing.
    Hofferbert S; Worringen U; Backe J; Rückert EM; White K; Faller H; Grimm T; Caffier H; Chang-Claude J; Weber BH
    Genet Couns; 2000; 11(2):127-46. PubMed ID: 10893664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population.
    Darooei M; Poornima S; Salma BU; Iyer GR; Pujar AN; Annapurna S; Shah A; Maddali S; Hasan Q
    Tumour Biol; 2017 Feb; 39(2):1010428317694303. PubMed ID: 28231738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.
    Eisen A; Rebbeck TR; Wood WC; Weber BL
    J Clin Oncol; 2000 May; 18(9):1980-95. PubMed ID: 10784640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M; Solomon S
    Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should women at increased risk for breast and ovarian cancer be randomized to prophylactic surgery? An ethical and empirical assessment.
    Tambor ES; Bernhardt BA; Geller G; Helzlsouer KJ; Doksum T; Holtzman NA
    J Womens Health Gend Based Med; 2000 Apr; 9(3):223-33. PubMed ID: 10787220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines.
    Julian-Reynier C; Eisinger F; Moatti JP; Sobol H
    Eur J Hum Genet; 2000 Mar; 8(3):204-8. PubMed ID: 10780786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
    McGee J; Giannakeas V; Karlan B; Lubinski J; Gronwald J; Rosen B; McLaughlin J; Risch H; Sun P; Foulkes WD; Neuhausen SL; Kotsopoulos J; Narod SA;
    Gynecol Oncol; 2017 May; 145(2):346-351. PubMed ID: 28314588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer.
    Claes E; Evers-Kiebooms G; Decruyenaere M; Denayer L; Boogaerts A; Philippe K; Legius E
    Behav Med; 2005; 31(3):93-105. PubMed ID: 16252621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer.
    Hurley KE; Miller SM; Costalas JW; Gillespie D; Daly MB
    J Womens Health Gend Based Med; 2001 Mar; 10(2):189-99. PubMed ID: 11268302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress of a Comprehensive Familial Cancer Genetic Counseling Program in the Era of BRCA1 and BRCA2.
    Hartenbach EM; Becker JM; Grosen EA; Bailey HH; Petereit DG; Laxova R; Schink JC
    Genet Test; 2002; 6(2):75-8. PubMed ID: 12229876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In cases of familial ovarian cancer, always consider the risk of breast cancer].
    Kets CM; Niermeijer MF; Massuger LF; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1709-11. PubMed ID: 15468897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Preventive Intervention of Hereditary Breast Cancer.
    Cao A; Huang L; Shao Z
    Adv Exp Med Biol; 2017; 1026():41-57. PubMed ID: 29282679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.